Mode
Text Size
Log in / Sign up
N/A Completed N=520 Randomized Single-blind Treatment

Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses

Source: ClinicalTrials.gov NCT01244516 ↗
Enrolled (actual)
520
Serious AEs
0.0%
Results posted
Jan 2012
Primary outcomePrimary: Overall Subjective Comfort — 51.7; 51.3; 51.3 CLUE score

Summary

The purpose of this study is to compare the clinical performance of three silicone hydrogel contact lenses over a 2 week period.

Outcome Measures

OutcomeResultp-value
PRIMARY
Overall Subjective Comfort
51.7; 51.3; 51.3 —
PRIMARY
Corneal Staining
78.5; 67.1; 66.1; 21.5; 32.9; 33.9 —
SECONDARY
Overall Subjective Lens Handling
64.3; 59.8 —

Eligibility Criteria

Inclusion Criteria

  • Be no less than 18 and no more than 39 years of age.
  • Sign Written Informed Consent and investigator to record this on Case Report Form.
  • Be willing and able to adhere to the instructions set out in the protocol.
  • Be an existing successful daily wear soft contact lens wearer. For the purposes of this study this means wearing lenses for at least 6 hours per day, 5 days per week for the last month.
  • No extended wear in the last 3 months.
  • Subjective refraction must result in a vertex corrected spherical contact lens prescription between -1.00 and -6.00 diopters.
  • Have refractive astigmatism less than or equal to 1.00 diopters (D) in both eyes.
  • Achieve visual acuity of 6/9 (20/30) or better in each eye.
  • Require a visual correction in both eyes (no monovision allowed).
  • Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: no amblyopia, no evidence of lid abnormality or infection (including blepharitis/meibomitis), no conjunctival abnormality or infection, no clinically significant slit lamp findings (i.e. stromal edema, vascularization, infiltrates or abnormal opacities), no other active ocular disease.

Exclusion Criteria

  • Requires concurrent ocular medication.
  • Clinically significant corneal stromal haze, corneal vascularization, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Clinically significant corneal staining
  • Requires presbyopic correction (i.e. Not using any presbyopic correction and measured add power of less than +1.00 diopters).
  • Has had refractive surgery.
  • Has had eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
  • Abnormal lacrimal secretions.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Keratoconus or other corneal irregularity.
  • Hard, hybrid or Rigid Gas Permeable lens wear in the previous 8 weeks.
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Diabetic.
  • Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease [e.g., Human immunodeficiency virus (HIV)].
  • History of chronic eye disease (e.g. glaucoma or Age Related Macular Degeneration).
  • Pregnancy, lactating or planning a pregnancy at the time of enrollment.
  • Participation in any concurrent clinical trial or in last 30 days
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01244516). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search